Related Articles
Promoter hypermethylation of cysteine dioxygenase type 1 in patients with non‑small cell lung cancer
Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers
Aberrant methylation of CXCL12 in non-small cell lung cancer is associated with an unfavorable prognosis Corrigendum in /ijo/47/2/791
Expression of endothelin-1 and endothelin-A and -B receptors in invasive bladder cancer
Hypermethylation of the PTTG1IP promoter leads to low expression in early‑stage non‑small cell lung cancer